GO Term |
GO Name |
Enriched Genes |
Log10 Adjusted P-value |
[BP] GO:0015701 |
bicarbonate transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
14.007 |
[BP] GO:0006730 |
one-carbon metabolic process
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
13.1098 |
[BP] GO:1901700 |
response to oxygen-containing compound
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA3, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, FABP3, HSD17B2, IGF1R, MMP2, MMP9, PPARA, SRC, TYR |
11.3747 |
[BP] GO:0010033 |
response to organic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CA3, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MMP2, PPARA, SRC, TYR |
10.2438 |
[BP] GO:0042221 |
response to chemical
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA2, CA3, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESRRA, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MMP2, MMP9, PPARA, SRC, TYR |
8.68191 |
[BP] GO:0014070 |
response to organic cyclic compound
|
ALPL, APEX1, BCL2, CA2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRA, FLT3, SRC, TYR |
8.58796 |
[BP] GO:0044281 |
small molecule metabolic process
|
AKR1B1, ALOX5, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, FABP3, FUT7, GLO1, PIM1, PPARA, TYR, XDH |
8.5822 |
[BP] GO:0006629 |
lipid metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD2, EGFR, ERBB2, ESR1, FABP3, FABP4, FUT7, HSD17B1, HSD17B2, MET, PPARA |
8.40097 |
[BP] GO:0009636 |
response to toxic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CA3, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, KDR, SRC |
8.35016 |
[BP] GO:0065008 |
regulation of biological quality
|
ACHE, ADORA1, ADRB1, AKR1B1, APEX1, AURKB, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CNR1, CNR2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, EGFR, ESR1, F2, F3, FABP3, FABP4, FLT3, HCAR2, HSD17B1, HSD17B2, KDR, MET, PPARA, SRC, XDH |
8.29389 |
[BP] GO:0008152 |
metabolic process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, SRC, TOP2A, TYR, XDH |
8.20749 |
[BP] GO:0019748 |
secondary metabolic process
|
AKR1B1, BCL2, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, TYR |
8.20749 |
[BP] GO:0015711 |
organic anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
8.19577 |
[BP] GO:0033993 |
response to lipid
|
ALPL, AXL, BCL2, CA2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, HSD17B2, SRC, TYR |
7.8441 |
[BP] GO:0032844 |
regulation of homeostatic process
|
ADORA1, AURKB, BCL2, CA2, CA7, CACNA1C, CNR1, DRD1, DRD2, DRD3, EGFR, F2, HCAR2, KDR, SRC |
7.46635 |
[BP] GO:2000021 |
regulation of ion homeostasis
|
ADORA1, BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, F2, KDR, SRC |
7.13961 |
[BP] GO:0010817 |
regulation of hormone levels
|
ACHE, ADORA1, AKR1B1, CACNA1C, CNR1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD2, EGFR, ESR1, HCAR2, HSD17B1, HSD17B2 |
7.11048 |
[BP] GO:0042493 |
response to drug
|
AKR1B1, APEX1, AXL, BCL2, CA3, CA9, CNR1, CNR2, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, FABP3, KDR, SRC |
6.83367 |
[BP] GO:0010941 |
regulation of cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SRC, TOP2A, XDH |
6.82755 |
[BP] GO:0010647 |
positive regulation of cell communication
|
ADORA1, ADRB1, AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F2, F3, FLT3, HCAR2, KDR, MET, MMP9, SRC, XDH |
6.81318 |
[BP] GO:0044237 |
cellular metabolic process
|
ACHE, AKR1B1, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, PIM1, PPARA, SRC, TOP2A, TYR, XDH |
6.81318 |
[BP] GO:0042592 |
homeostatic process
|
ADORA1, ADRB1, AKR1B1, APEX1, AXL, BCL2, CA12, CA2, CA7, CACNA1C, CNR1, DRD1, DRD2, DRD3, EGFR, ESR1, F2, FABP3, FABP4, FLT3, MET, SRC |
6.81318 |
[BP] GO:0006820 |
anion transport
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, DRD2, DRD3, FABP3, PPARA |
6.81318 |
[BP] GO:0023056 |
positive regulation of signaling
|
ADORA1, ADRB1, AKR1B1, AXL, BCL2, CA2, CA7, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F2, F3, FLT3, HCAR2, KDR, MET, MMP9, SRC, XDH |
6.81318 |
[BP] GO:0009719 |
response to endogenous stimulus
|
AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, DRD1, EGFR, ERBB2, ESR1, ESRRA, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC |
6.75615 |
[BP] GO:0043067 |
regulation of programmed cell death
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, SRC, TOP2A, XDH |
6.75615 |
[BP] GO:0010035 |
response to inorganic substance
|
AKR1B1, APEX1, AXL, BCL2, CA2, CYP1A1, CYP1A2, CYP1B1, DRD2, EGFR, FABP4, KDR, MMP9, SRC |
6.75615 |
[BP] GO:0032502 |
developmental process
|
ACHE, ADORA1, ADRB1, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CACNA1C, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESRRA, ESRRB, F2, FABP4, FLT3, FUT7, GLO1, HSD17B2, KDR, MET, MMP2, MMP9, PIM1, PPARA, SRC, TOP2A, TYR |
6.71505 |
[BP] GO:0032228 |
regulation of synaptic transmission, GABAergic
|
ADORA1, CA2, CA7, CNR1, CNR2, DRD2 |
6.33805 |
[BP] GO:0048513 |
animal organ development
|
ACHE, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, EGFR, ERBB2, ESR1, ESRRA, ESRRB, FLT3, HSD17B2, KDR, PPARA, SRC, TYR |
6.32353 |
[BP] GO:0042127 |
regulation of cell proliferation
|
ADORA1, ADORA3, AKR1B1, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESRRA, F2, F3, FABP3, FLT3, IGF1R, KDR, MMP2, MMP9, PIM1, SRC, XDH |
6.22614 |
[BP] GO:0048522 |
positive regulation of cellular process
|
ACHE, ADORA1, ADRB1, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, HCAR2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, SRC, TOP2A, XDH |
6.21436 |
[BP] GO:0042981 |
regulation of apoptotic process
|
ADORA1, AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, EGFR, ESR1, F3, FLT3, GLO1, HCAR2, IGF1R, KDR, MMP9, PIM1, SRC, TOP2A, XDH |
6.14072 |
[BP] GO:0034754 |
cellular hormone metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
5.93205 |
[BP] GO:0050896 |
response to stimulus
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA3, CA6, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESRRA, F2, F3, FABP3, FABP4, FLT3, HSD17B2, IGF1R, KDR, MMP2, MMP9, PPARA, SRC, TOP2A, TYR |
5.87518 |
[BP] GO:0009725 |
response to hormone
|
AKR1B1, ALPL, APEX1, BCL2, CA2, CA9, CSNK2A1, CYP1A2, EGFR, ESR1, ESRRA, FABP3, FLT3, PPARA, SRC |
5.84603 |
[BP] GO:0040012 |
regulation of locomotion
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, IGF1R, KDR, MET, MMP9, SRC |
5.82129 |
[BP] GO:0032846 |
positive regulation of homeostatic process
|
AURKB, CA2, CA7, CNR1, DRD1, DRD2, DRD3, EGFR, F2, HCAR2 |
5.82129 |
[BP] GO:0051270 |
regulation of cellular component movement
|
ADORA1, ADORA3, APEX1, BCL2, CACNA1C, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, F3, IGF1R, KDR, MET, MMP9, SRC |
5.81053 |
[BP] GO:0010646 |
regulation of cell communication
|
ACHE, ADORA1, ADRB1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, F2, F3, FLT3, HCAR2, IGF1R, KDR, MET, MMP9, SRC, XDH |
5.78754 |
[BP] GO:0045776 |
None
|
ADORA1, ADRB1, CNR1, DRD2, DRD3, PPARA |
5.70941 |
[BP] GO:0023051 |
regulation of signaling
|
ACHE, ADORA1, ADRB1, AKR1B1, AURKB, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, F2, F3, FLT3, HCAR2, IGF1R, KDR, MET, MMP9, SRC, XDH |
5.66884 |
[BP] GO:0019373 |
epoxygenase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
5.60406 |
[BP] GO:0032501 |
multicellular organismal process
|
ADORA1, ADRB1, AKR1B1, ALOX5, ALPL, AXL, BCL2, CACNA1C, CNR1, CNR2, CYP19A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ESR1, ESRRB, F2, F3, FABP4, HSD17B2, IGF1R, MET, MMP1, MMP2, MMP9, PIM1, PPARA, SRC, TYR |
5.56225 |
[BP] GO:0009611 |
response to wounding
|
ACHE, ADORA3, BCL2, CYP1A1, DRD2, EGFR, ERBB2, F2, PPARA |
5.56225 |
[BP] GO:0008202 |
steroid metabolic process
|
AKR1B1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, ESR1, HSD17B1, HSD17B2 |
5.52072 |
[BP] GO:2000145 |
regulation of cell motility
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, ERBB2, F3, IGF1R, KDR, MET, MMP9, SRC |
5.51594 |
[BP] GO:0042445 |
hormone metabolic process
|
ACHE, AKR1B1, CYP19A1, CYP1A1, CYP1B1, CYP3A4, ESR1, HSD17B1, HSD17B2 |
5.46248 |
[BP] GO:0044255 |
cellular lipid metabolic process
|
ACHE, ALOX5, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD2, EGFR, ERBB2, FABP3, FABP4, FUT7, MET, PPARA |
5.40441 |
[BP] GO:0046777 |
protein autophosphorylation
|
AURKB, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, PIM1, SRC |
5.26233 |
[BP] GO:0048518 |
positive regulation of biological process
|
ACHE, ADORA1, ADRB1, AKR1B1, APEX1, AURKB, AXL, BCL2, CA2, CA7, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, HCAR2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, SRC, TOP2A, XDH |
5.25345 |
[BP] GO:0010243 |
response to organonitrogen compound
|
AKR1B1, APEX1, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC, TYR |
5.14942 |
[BP] GO:0008284 |
positive regulation of cell proliferation
|
AKR1B1, BCL2, CSNK2A1, DRD2, DRD3, EGFR, ERBB2, ESR1, F2, F3, FLT3, IGF1R, KDR, MMP2, MMP9, PIM1 |
5.12782 |
[BP] GO:0032879 |
regulation of localization
|
ACHE, ADORA1, ADORA3, APEX1, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, F2, F3, HCAR2, IGF1R, KDR, MET, MMP9, PPARA, SRC |
5.09487 |
[BP] GO:0030334 |
regulation of cell migration
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD1, DRD2, EGFR, F3, IGF1R, KDR, MET, MMP9, SRC |
5.07634 |
[BP] GO:0051896 |
regulation of protein kinase B signaling
|
AXL, DRD2, DRD3, EGFR, ERBB2, F3, MET, SRC, XDH |
5.02718 |
[BP] GO:0048511 |
rhythmic process
|
AXL, BCL2, CSNK2A1, DRD2, DRD3, EGFR, ESR1, PPARA, SRC, TOP2A |
5.02718 |
[BP] GO:0032101 |
regulation of response to external stimulus
|
ADORA1, CNR1, CNR2, CYP19A1, DRD1, DRD2, DRD3, EGFR, ESR1, F2, F3, FABP4, KDR, MET, PPARA |
5.01152 |
[BP] GO:1902531 |
regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ERBB2, ESR1, F2, F3, FLT3, IGF1R, KDR, MET, MMP9, SRC, XDH |
4.85474 |
[BP] GO:0050804 |
modulation of chemical synaptic transmission
|
ACHE, ADORA1, CA2, CA7, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR |
4.81571 |
[BP] GO:0099177 |
regulation of trans-synaptic signaling
|
ACHE, ADORA1, CA2, CA7, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR |
4.81571 |
[BP] GO:0048878 |
chemical homeostasis
|
AKR1B1, BCL2, CA12, CA2, CA7, CACNA1C, CNR1, DRD1, DRD2, DRD3, EGFR, ESR1, F2, FABP3, FABP4, MET |
4.78624 |
[BP] GO:1901698 |
response to nitrogen compound
|
AKR1B1, APEX1, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, FABP3, FLT3, IGF1R, MMP2, PPARA, SRC, TYR |
4.77253 |
[BP] GO:0034614 |
cellular response to reactive oxygen species
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
4.74219 |
[BP] GO:1902533 |
positive regulation of intracellular signal transduction
|
ADORA1, ADRB1, AKR1B1, AXL, BCL2, CYP1B1, DRD2, EGFR, ERBB2, F2, F3, FLT3, KDR, MET, SRC, XDH |
4.60733 |
[BP] GO:0048856 |
anatomical structure development
|
ACHE, ADORA1, AKR1B1, ALPL, AXL, BCL2, CA2, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESRRA, ESRRB, F2, FLT3, HSD17B2, KDR, MMP9, PIM1, PPARA, SRC, TYR |
4.55542 |
[BP] GO:0000302 |
response to reactive oxygen species
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, EGFR, MMP9, SRC |
4.55496 |
[BP] GO:0032847 |
regulation of cellular pH reduction
|
BCL2, CA2, CA7 |
4.478 |
[BP] GO:0017144 |
drug metabolic process
|
ACHE, AKR1B1, AOX1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, DRD1, DRD2, DRD3, EGFR |
4.42972 |
[BP] GO:0048523 |
negative regulation of cellular process
|
ACHE, ADORA1, ADORA3, AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, GLO1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SRC, TOP2A, XDH |
4.42408 |
[BP] GO:0018108 |
peptidyl-tyrosine phosphorylation
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.35484 |
[BP] GO:0048519 |
negative regulation of biological process
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, APEX1, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, FABP4, GLO1, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SRC, TOP2A, XDH |
4.34396 |
[BP] GO:0055114 |
oxidation-reduction process
|
AKR1B1, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HSD17B1, HSD17B2, TYR, XDH |
4.33643 |
[BP] GO:0018212 |
peptidyl-tyrosine modification
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.31458 |
[BP] GO:0018958 |
None
|
AKR1B1, BCL2, DRD1, DRD2, DRD3, TYR |
4.28803 |
[BP] GO:0070887 |
cellular response to chemical stimulus
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ERBB2, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, SRC |
4.2769 |
[BP] GO:0048585 |
negative regulation of response to stimulus
|
ADORA1, BCL2, CNR1, CNR2, CYP19A1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, F2, IGF1R, MET, MMP9, PPARA, SRC, XDH |
4.27653 |
[BP] GO:0048584 |
positive regulation of response to stimulus
|
ADORA1, ADRB1, AKR1B1, AXL, BCL2, CNR1, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ERBB2, ESRRA, F2, F3, FABP4, FLT3, KDR, MET, MMP2, MMP9, SRC, XDH |
4.23003 |
[BP] GO:0009967 |
positive regulation of signal transduction
|
ADORA1, ADRB1, AKR1B1, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ERBB2, F2, F3, FLT3, KDR, MET, MMP9, SRC, XDH |
4.15959 |
[BP] GO:0019216 |
regulation of lipid metabolic process
|
ADORA1, CNR1, CYP1A1, DRD3, F2, FABP3, FLT3, HCAR2, PPARA, SRC |
4.15527 |
[BP] GO:0071310 |
cellular response to organic substance
|
AKR1B1, ALPL, APEX1, AXL, BCL2, CYP1A1, CYP1B1, DRD1, EGFR, ERBB2, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, SRC |
4.12598 |
[BP] GO:0060548 |
negative regulation of cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SRC |
4.04156 |
[BP] GO:0033559 |
unsaturated fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.78354 |
[BP] GO:0009628 |
response to abiotic stimulus
|
ADORA1, ADRB1, AKR1B1, AURKB, BCL2, CA2, CYP1A1, DRD1, DRD2, DRD3, EGFR, MMP2, PPARA, SRC, TYR |
3.78051 |
[BP] GO:0043069 |
negative regulation of programmed cell death
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, IGF1R, KDR, MET, MMP9, PIM1, SRC |
3.77564 |
[BP] GO:0006811 |
None
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, DRD1, DRD2, DRD3, FABP3, PPARA |
3.75765 |
[BP] GO:0019369 |
arachidonic acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.73671 |
[BP] GO:0018193 |
peptidyl-amino acid modification
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, EGFR, ERBB2, F2, FLT3, IGF1R, KDR, MET, SRC, TOP2A |
3.73334 |
[BP] GO:0044092 |
negative regulation of molecular function
|
ADORA3, AURKB, CNR1, CNR2, CSNK2A1, CYP1B1, DRD2, DRD3, ESR1, FABP4, IGF1R, MET, MMP9, PIM1, PPARA, SRC |
3.69904 |
[BP] GO:1901615 |
organic hydroxy compound metabolic process
|
AKR1B1, BCL2, CYP19A1, CYP1A1, CYP1B1, CYP3A4, DRD1, DRD2, DRD3, TYR |
3.69904 |
[BP] GO:0008210 |
estrogen metabolic process
|
CYP19A1, CYP1B1, HSD17B1, HSD17B2 |
3.69071 |
[BP] GO:0009698 |
phenylpropanoid metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.66862 |
[BP] GO:0009804 |
coumarin metabolic process
|
CYP1A1, CYP2A13, CYP2A6 |
3.66862 |
[BP] GO:0006690 |
icosanoid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
3.64395 |
[BP] GO:0051966 |
regulation of synaptic transmission, glutamatergic
|
ADORA1, CNR1, DRD1, DRD2, EGFR |
3.57375 |
[BP] GO:0008283 |
cell proliferation
|
ACHE, AURKB, BCL2, CYP1A1, EGFR, ERBB2, ESR1, FLT3, MET, PIM1, SRC, TYR |
3.57208 |
[BP] GO:0001975 |
None
|
CNR2, DRD1, DRD2, DRD3 |
3.56812 |
[BP] GO:0042542 |
response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, BCL2, CYP1B1, SRC |
3.56427 |
[BP] GO:0009987 |
cellular process
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HCAR2, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, SRC, TOP2A, TYR, XDH |
3.55163 |
[BP] GO:0048583 |
regulation of response to stimulus
|
ADORA1, ADRB1, AKR1B1, AURKB, AXL, BCL2, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, F2, F3, FABP4, FLT3, IGF1R, KDR, MET, MMP2, MMP9, PPARA, SRC, XDH |
3.55163 |
[BP] GO:0042446 |
hormone biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD17B1, HSD17B2 |
3.52051 |
[BP] GO:0030522 |
intracellular receptor signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PIM1, PPARA, SRC |
3.50756 |
[BP] GO:0051240 |
positive regulation of multicellular organismal process
|
ADRB1, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, DRD3, EGFR, ESRRB, F2, F3, HCAR2, KDR, MET, MMP9, PIM1, SRC |
3.50756 |
[BP] GO:0051940 |
None
|
DRD1, DRD2, DRD3 |
3.50756 |
[BP] GO:0051584 |
None
|
DRD1, DRD2, DRD3 |
3.50756 |
[BP] GO:0050801 |
ion homeostasis
|
BCL2, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EGFR, ESR1, F2, FABP3 |
3.50167 |
[BP] GO:0006979 |
response to oxidative stress
|
AKR1B1, APEX1, AXL, BCL2, CA3, CYP1B1, EGFR, MMP9, SRC |
3.4938 |
[BP] GO:0007165 |
signal transduction
|
ADORA1, ADORA3, ADRB1, AKR1B1, AXL, BCL2, CA1, CA2, CACNA1C, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HCAR2, IGF1R, KDR, MET, MMP2, MMP9, PIM1, PPARA, SRC |
3.46593 |
[BP] GO:0050805 |
negative regulation of synaptic transmission
|
ACHE, ADORA1, CNR2, DRD1, DRD2 |
3.44376 |
[BP] GO:0071407 |
cellular response to organic cyclic compound
|
ALPL, APEX1, CYP1A1, CYP1B1, DRD1, EGFR, ESR1, FLT3, SRC |
3.42375 |
[BP] GO:0051239 |
regulation of multicellular organismal process
|
ADORA1, ADORA3, ADRB1, AXL, BCL2, CA2, CACNA1C, CNR1, CYP1B1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESRRA, ESRRB, F2, F3, HCAR2, KDR, MET, MMP9, PIM1, SRC, XDH |
3.41247 |
[BP] GO:0007187 |
None
|
ADORA1, ADRB1, CNR1, CNR2, DRD1, DRD2, DRD3 |
3.40794 |
[BP] GO:0019220 |
regulation of phosphate metabolic process
|
ADORA1, ADRB1, BCL2, DRD1, DRD2, DRD3, EGFR, ERBB2, ESRRB, F2, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, PPARA, SRC, XDH |
3.40446 |
[BP] GO:0048871 |
multicellular organismal homeostasis
|
ADORA1, ADRB1, AKR1B1, DRD1, DRD2, MET |
3.39148 |
[BP] GO:0010562 |
positive regulation of phosphorus metabolic process
|
ADORA1, ADRB1, BCL2, DRD1, DRD2, EGFR, ERBB2, ESRRB, F2, FABP3, FLT3, KDR, MMP9, SRC, XDH |
3.38284 |
[BP] GO:0045937 |
positive regulation of phosphate metabolic process
|
ADORA1, ADRB1, BCL2, DRD1, DRD2, EGFR, ERBB2, ESRRB, F2, FABP3, FLT3, KDR, MMP9, SRC, XDH |
3.38284 |
[BP] GO:0051174 |
regulation of phosphorus metabolic process
|
ADORA1, ADRB1, BCL2, DRD1, DRD2, DRD3, EGFR, ERBB2, ESRRB, F2, FABP3, FABP4, FLT3, IGF1R, KDR, MMP9, PPARA, SRC, XDH |
3.36992 |
[BP] GO:0050790 |
regulation of catalytic activity
|
ADORA1, ADORA3, ADRB1, AURKB, BCL2, CNR1, CNR2, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, F2, F3, FABP4, FLT3, IGF1R, MMP9, SRC, XDH |
3.36642 |
[BP] GO:0051050 |
positive regulation of transport
|
ACHE, ADORA1, AXL, BCL2, CA2, CYP19A1, DRD1, DRD2, DRD3, EGFR, ERBB2, F2, HCAR2, SRC |
3.36642 |
[BP] GO:0050806 |
positive regulation of synaptic transmission
|
ADORA1, CA2, CA7, DRD1, DRD2, EGFR |
3.35048 |
[BP] GO:0001659 |
None
|
ADORA1, ADRB1, DRD1, DRD2 |
3.33069 |
[BP] GO:0034599 |
cellular response to oxidative stress
|
AKR1B1, APEX1, AXL, CYP1B1, EGFR, MMP9, SRC |
3.27663 |
[BP] GO:0010648 |
negative regulation of cell communication
|
ACHE, ADORA1, BCL2, CNR2, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, IGF1R, MET, MMP9, SRC, XDH |
3.27663 |
[BP] GO:0051173 |
positive regulation of nitrogen compound metabolic process
|
ADORA1, ADRB1, AURKB, BCL2, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, IGF1R, KDR, MET, MMP9, PPARA, SRC, TOP2A, XDH |
3.2646 |
[BP] GO:0023057 |
negative regulation of signaling
|
ACHE, ADORA1, BCL2, CNR2, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, IGF1R, MET, MMP9, SRC, XDH |
3.2646 |
[BP] GO:0065009 |
regulation of molecular function
|
ADORA1, ADORA3, ADRB1, AURKB, BCL2, CNR1, CNR2, CSNK2A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, F2, F3, FABP4, FLT3, IGF1R, MET, MMP9, PIM1, PPARA, SRC, XDH |
3.2573 |
[BP] GO:0032102 |
negative regulation of response to external stimulus
|
ADORA1, CNR2, CYP19A1, DRD1, DRD2, DRD3, F2, PPARA |
3.2573 |
[BP] GO:0097267 |
omega-hydroxylase P450 pathway
|
CYP1A1, CYP1A2, CYP1B1 |
3.25475 |
[BP] GO:0043066 |
negative regulation of apoptotic process
|
ADORA1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, EGFR, GLO1, IGF1R, KDR, MMP9, PIM1, SRC |
3.23209 |
[BP] GO:0035690 |
cellular response to drug
|
AKR1B1, APEX1, AXL, CYP1B1, DRD1, EGFR, KDR, SRC |
3.23083 |
[BP] GO:0006950 |
response to stress
|
ACHE, ADORA1, ADORA3, ADRB1, AKR1B1, APEX1, AXL, BCL2, CA2, CA3, CA9, CNR2, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, EGFR, ERBB2, F2, MMP2, MMP9, PPARA, SRC, TOP2A |
3.21181 |
[BP] GO:0009891 |
positive regulation of biosynthetic process
|
ADRB1, AURKB, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, FABP3, IGF1R, KDR, MET, PPARA, SRC, TOP2A |
3.20783 |
[BP] GO:0043401 |
steroid hormone mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
3.20658 |
[BP] GO:0043269 |
regulation of ion transport
|
ADORA1, BCL2, CA2, CA7, CACNA1C, CNR1, DRD1, DRD2, DRD3, F2, MMP9 |
3.17568 |
[BP] GO:0021885 |
forebrain cell migration
|
AXL, DRD1, DRD2, EGFR |
3.15403 |
[BP] GO:0051952 |
None
|
ADORA1, CNR1, DRD1, DRD2, DRD3 |
3.15403 |
[BP] GO:0050727 |
regulation of inflammatory response
|
ADORA1, CNR1, CNR2, CYP19A1, EGFR, ESR1, F2, FABP4, PPARA |
3.15065 |
[BP] GO:0009056 |
catabolic process
|
ACHE, ADORA1, AOX1, AURKB, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A6, CYP3A4, FABP3, FABP4, FUT7, MMP1, MMP2, MMP9, SRC, XDH |
3.13572 |
[BP] GO:0007169 |
transmembrane receptor protein tyrosine kinase signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, SRC |
3.13256 |
[BP] GO:0006631 |
fatty acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, PPARA |
3.10127 |
[BP] GO:0051049 |
regulation of transport
|
ACHE, ADORA1, AXL, BCL2, CA2, CA7, CACNA1C, CNR1, CYP19A1, DRD1, DRD2, DRD3, EGFR, ERBB2, F2, HCAR2, MMP9, PPARA, SRC |
3.06093 |
[BP] GO:0042738 |
exogenous drug catabolic process
|
CYP1A2, CYP2A6, CYP3A4 |
3.0311 |
[BP] GO:0043271 |
negative regulation of ion transport
|
ADORA1, BCL2, CNR1, DRD2, DRD3, MMP9 |
3.0311 |
[BP] GO:0014075 |
None
|
CNR2, DRD1, DRD2, DRD3 |
3.0311 |
[BP] GO:0022414 |
reproductive process
|
AKR1B1, ALPL, AXL, BCL2, CNR1, CYP19A1, CYP1A1, DRD1, EGFR, ESR1, ESRRB, HSD17B2, MMP2, MMP9, SRC, TOP2A |
3.02985 |
[BP] GO:0051716 |
cellular response to stimulus
|
AKR1B1, ALPL, APEX1, AURKB, AXL, BCL2, CA2, CA9, CYP1A1, CYP1A2, CYP1B1, DRD1, EGFR, ERBB2, ESR1, FABP4, FLT3, IGF1R, KDR, MMP2, MMP9, SRC, TOP2A |
3.02985 |
[BP] GO:0031325 |
positive regulation of cellular metabolic process
|
ADORA1, ADRB1, AURKB, BCL2, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, IGF1R, KDR, MET, MMP9, PPARA, SRC, TOP2A, XDH |
3.02721 |
[BP] GO:0098771 |
inorganic ion homeostasis
|
BCL2, CA12, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EGFR, ESR1, F2 |
2.98852 |
[BP] GO:0009410 |
None
|
CNR1, CNR2, DRD1, DRD2, DRD3, EGFR |
2.95738 |
[BP] GO:0006703 |
estrogen biosynthetic process
|
CYP19A1, HSD17B1, HSD17B2 |
2.94095 |
[BP] GO:0060134 |
None
|
DRD1, DRD2, DRD3 |
2.94095 |
[BP] GO:0008217 |
None
|
ADORA1, ADRB1, CNR1, DRD2, DRD3, PPARA |
2.92037 |
[BP] GO:0031347 |
regulation of defense response
|
ADORA1, CNR1, CNR2, CYP19A1, DRD2, EGFR, ESR1, F2, FABP4, MMP2, PPARA, SRC |
2.91936 |
[BP] GO:0009115 |
None
|
AOX1, XDH |
2.91579 |
[BP] GO:0010038 |
response to metal ion
|
BCL2, CA2, CYP1A1, CYP1A2, DRD2, EGFR, FABP4, MMP9 |
2.91252 |
[BP] GO:0051897 |
positive regulation of protein kinase B signaling
|
AXL, EGFR, ERBB2, F3, MET, SRC |
2.88418 |
[BP] GO:0006468 |
protein phosphorylation
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.88418 |
[BP] GO:2001023 |
None
|
CNR1, DRD1, DRD2, DRD3, MET |
2.88121 |
[BP] GO:0060065 |
uterus development
|
CYP19A1, ESR1, SRC |
2.86557 |
[BP] GO:0051580 |
None
|
DRD1, DRD2, DRD3 |
2.86557 |
[BP] GO:0006584 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.86427 |
[BP] GO:0009712 |
None
|
AKR1B1, DRD1, DRD2, DRD3 |
2.86427 |
[BP] GO:1901568 |
fatty acid derivative metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
2.85048 |
[BP] GO:0019932 |
second-messenger-mediated signaling
|
ADRB1, CACNA1C, DRD1, DRD2, DRD3, EGFR, KDR |
2.84484 |
[BP] GO:0007188 |
None
|
ADORA1, ADRB1, CNR1, DRD1, DRD2, DRD3 |
2.83872 |
[BP] GO:0090087 |
None
|
ACHE, ADORA1, CA2, CACNA1C, CNR1, DRD2, DRD3, EGFR, ERBB2, F2, HCAR2, SRC |
2.81576 |
[BP] GO:0009893 |
positive regulation of metabolic process
|
ADORA1, ADRB1, AURKB, BCL2, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FLT3, IGF1R, KDR, MET, MMP9, PPARA, SRC, TOP2A, XDH |
2.81456 |
[BP] GO:0006796 |
phosphate-containing compound metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, BCL2, CA3, CSNK2A1, DRD1, DRD2, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC, XDH |
2.79901 |
[BP] GO:0097366 |
None
|
CNR2, DRD1, DRD2, DRD3 |
2.79901 |
[BP] GO:0001963 |
None
|
DRD1, DRD2, DRD3 |
2.7923 |
[BP] GO:0030335 |
positive regulation of cell migration
|
BCL2, DRD1, EGFR, F3, IGF1R, KDR, MET, MMP9, SRC |
2.78856 |
[BP] GO:1901564 |
organonitrogen compound metabolic process
|
ACHE, AKR1B1, ALPL, AOX1, AURKB, AXL, BCL2, CSNK2A1, CYP1A1, CYP1A2, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, F2, F3, FLT3, FUT7, GLO1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, SRC, TOP2A, TYR, XDH |
2.74424 |
[BP] GO:0038083 |
peptidyl-tyrosine autophosphorylation
|
EGFR, IGF1R, KDR, SRC |
2.73305 |
[BP] GO:0002791 |
None
|
ACHE, ADORA1, CACNA1C, CNR1, DRD2, DRD3, EGFR, HCAR2, SRC |
2.72081 |
[BP] GO:0016477 |
cell migration
|
AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, F2, FUT7, KDR, MMP1, MMP9, SRC |
2.72081 |
[BP] GO:0042752 |
None
|
ADORA1, DRD2, DRD3, PPARA, TOP2A |
2.72081 |
[BP] GO:0030540 |
female genitalia development
|
AXL, CYP19A1, ESR1 |
2.72081 |
[BP] GO:0032225 |
None
|
DRD1, DRD2, DRD3 |
2.72081 |
[BP] GO:0080134 |
regulation of response to stress
|
ADORA1, CNR1, CNR2, CYP19A1, DRD2, EGFR, ESR1, F2, F3, FABP4, IGF1R, MET, MMP2, PPARA, SRC, XDH |
2.70679 |
[BP] GO:0009755 |
hormone-mediated signaling pathway
|
ESR1, ESR2, ESRRA, ESRRB, PPARA, SRC |
2.70451 |
[BP] GO:2000147 |
positive regulation of cell motility
|
BCL2, DRD1, EGFR, F3, IGF1R, KDR, MET, MMP9, SRC |
2.6899 |
[BP] GO:0001676 |
long-chain fatty acid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6 |
2.68894 |
[BP] GO:0045927 |
positive regulation of growth
|
BCL2, CSNK2A1, DRD2, EGFR, ERBB2, F2, PIM1 |
2.65957 |
[BP] GO:0031348 |
negative regulation of defense response
|
ADORA1, CNR2, CYP19A1, DRD2, F2, PPARA |
2.65586 |
[BP] GO:0072593 |
reactive oxygen species metabolic process
|
BCL2, CYP1A1, CYP1A2, CYP1B1, EGFR |
2.65291 |
[BP] GO:0001666 |
response to hypoxia
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC |
2.62204 |
[BP] GO:0044238 |
primary metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, SRC, TOP2A, TYR, XDH |
2.62204 |
[BP] GO:0051272 |
positive regulation of cellular component movement
|
BCL2, DRD1, EGFR, F3, IGF1R, KDR, MET, MMP9, SRC |
2.60744 |
[BP] GO:0050994 |
None
|
ADORA1, CNR1, HCAR2, PPARA |
2.59146 |
[BP] GO:0009895 |
negative regulation of catabolic process
|
ADORA1, BCL2, CNR1, EGFR, HCAR2, MET, PPARA |
2.58842 |
[BP] GO:0046883 |
regulation of hormone secretion
|
ADORA1, CACNA1C, CNR1, CYP19A1, DRD2, EGFR, HCAR2 |
2.58842 |
[BP] GO:0048869 |
cellular developmental process
|
ACHE, ADRB1, ALPL, AXL, BCL2, CYP1A1, DRD1, DRD2, EGFR, ERBB2, ESR1, ESRRB, FABP4, FLT3, FUT7, GLO1, KDR, MET, MMP2, MMP9, SRC, TOP2A |
2.5869 |
[BP] GO:0042325 |
regulation of phosphorylation
|
ADORA1, BCL2, DRD1, DRD2, EGFR, ERBB2, ESRRB, F2, FABP4, FLT3, IGF1R, KDR, MMP9, PPARA, SRC, XDH |
2.58527 |
[BP] GO:0071704 |
organic substance metabolic process
|
ACHE, ADORA1, AKR1B1, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, BCL2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, SRC, TOP2A, TYR, XDH |
2.58527 |
[BP] GO:0030336 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.57516 |
[BP] GO:0006793 |
phosphorus metabolic process
|
ACHE, ALPL, APEX1, AURKB, AXL, BCL2, CA3, CSNK2A1, DRD1, DRD2, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC, XDH |
2.57516 |
[BP] GO:0006721 |
terpenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
2.57428 |
[BP] GO:0032787 |
None
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, PPARA |
2.56815 |
[BP] GO:0040011 |
locomotion
|
AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, F2, FUT7, KDR, MET, MMP1, MMP9, SRC |
2.56257 |
[BP] GO:0036293 |
response to decreased oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC |
2.56257 |
[BP] GO:0046110 |
None
|
AOX1, XDH |
2.54706 |
[BP] GO:0060160 |
None
|
DRD2, DRD3 |
2.54706 |
[BP] GO:0032849 |
positive regulation of cellular pH reduction
|
CA2, CA7 |
2.54706 |
[BP] GO:0033602 |
None
|
CNR1, DRD2 |
2.54706 |
[BP] GO:0097164 |
None
|
ACHE, AKR1B1, CSNK2A1, DRD1, DRD2, DRD3 |
2.54706 |
[BP] GO:0016042 |
lipid catabolic process
|
ADORA1, CYP19A1, CYP1A2, CYP1B1, CYP3A4, FABP3, FABP4 |
2.54706 |
[BP] GO:0045187 |
None
|
ADORA1, DRD2, DRD3 |
2.54668 |
[BP] GO:0051900 |
regulation of mitochondrial depolarization
|
BCL2, KDR, SRC |
2.54668 |
[BP] GO:0040017 |
positive regulation of locomotion
|
BCL2, DRD1, EGFR, F3, IGF1R, KDR, MET, MMP9, SRC |
2.53234 |
[BP] GO:1901701 |
cellular response to oxygen-containing compound
|
AKR1B1, APEX1, AXL, CYP1B1, DRD1, EGFR, ESR1, IGF1R, MMP2, MMP9, SRC |
2.4903 |
[BP] GO:0032496 |
response to lipopolysaccharide
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, SRC |
2.4903 |
[BP] GO:0048148 |
None
|
DRD1, DRD2, DRD3 |
2.4903 |
[BP] GO:0035813 |
None
|
ADORA1, DRD2, DRD3 |
2.4903 |
[BP] GO:0019222 |
regulation of metabolic process
|
ACHE, ADORA1, ADORA3, ADRB1, APEX1, AURKB, BCL2, CA9, CNR1, CNR2, CSNK2A1, CYP1A1, CYP1A2, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SRC, TOP2A, XDH |
2.48524 |
[BP] GO:0001503 |
ossification
|
ALPL, BCL2, EGFR, MMP2, MMP9 |
2.48524 |
[BP] GO:0006805 |
xenobiotic metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
2.48524 |
[BP] GO:0051047 |
None
|
ACHE, ADORA1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, SRC |
2.48507 |
[BP] GO:0032103 |
positive regulation of response to external stimulus
|
CNR1, EGFR, F2, F3, FABP4, KDR, MET |
2.48269 |
[BP] GO:2000146 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.47442 |
[BP] GO:0050728 |
negative regulation of inflammatory response
|
ADORA1, CNR2, CYP19A1, F2, PPARA |
2.47375 |
[BP] GO:0010604 |
positive regulation of macromolecule metabolic process
|
ADORA1, AURKB, BCL2, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, IGF1R, KDR, MET, MMP9, PPARA, SRC, TOP2A, XDH |
2.47336 |
[BP] GO:0002009 |
morphogenesis of an epithelium
|
BCL2, CA2, CA9, EGFR, ESR1, MET, SRC |
2.45989 |
[BP] GO:0055080 |
cation homeostasis
|
BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, EGFR, ESR1, F2 |
2.45989 |
[BP] GO:0070988 |
demethylation
|
APEX1, CYP1A1, CYP1A2, CYP3A4 |
2.44497 |
[BP] GO:0042749 |
None
|
ADORA1, DRD2, DRD3 |
2.44497 |
[BP] GO:0009416 |
response to light stimulus
|
AURKB, BCL2, DRD1, DRD2, DRD3, EGFR, TYR |
2.43666 |
[BP] GO:0048870 |
cell motility
|
AXL, CNR2, CYP1B1, DRD1, DRD2, EGFR, F2, FUT7, KDR, MMP1, MMP9, SRC |
2.41903 |
[BP] GO:0097237 |
cellular response to toxic substance
|
AKR1B1, APEX1, AXL, CYP1B1, KDR |
2.39774 |
[BP] GO:0070301 |
cellular response to hydrogen peroxide
|
AKR1B1, APEX1, AXL, CYP1B1 |
2.39457 |
[BP] GO:0030520 |
intracellular estrogen receptor signaling pathway
|
ESR1, ESR2, SRC |
2.39152 |
[BP] GO:0050995 |
None
|
ADORA1, CNR1, HCAR2 |
2.39152 |
[BP] GO:0070482 |
response to oxygen levels
|
ADORA1, BCL2, CYP1A1, DRD2, MMP2, PPARA, SRC |
2.38866 |
[BP] GO:1902532 |
negative regulation of intracellular signal transduction
|
BCL2, DRD2, DRD3, ESR1, IGF1R, MET, MMP9, SRC, XDH |
2.37903 |
[BP] GO:0042391 |
None
|
ADORA1, BCL2, CACNA1C, CNR1, CNR2, DRD1, KDR, SRC |
2.372 |
[BP] GO:0045834 |
positive regulation of lipid metabolic process
|
F2, FABP3, FLT3, PPARA, SRC |
2.35865 |
[BP] GO:0051271 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.35246 |
[BP] GO:0002237 |
response to molecule of bacterial origin
|
ALPL, AXL, CNR1, CNR2, CYP1A1, CYP1A2, SRC |
2.35246 |
[BP] GO:0031328 |
positive regulation of cellular biosynthetic process
|
ADRB1, AURKB, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, FABP3, IGF1R, MET, PPARA, SRC, TOP2A |
2.35246 |
[BP] GO:0046486 |
glycerolipid metabolic process
|
ACHE, CSNK2A1, DRD2, EGFR, ERBB2, FABP3, FABP4, MET |
2.34966 |
[BP] GO:0051953 |
None
|
ADORA1, CNR1, DRD2 |
2.34966 |
[BP] GO:0044062 |
None
|
ADORA1, DRD2, DRD3 |
2.34966 |
[BP] GO:0009404 |
toxin metabolic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.34966 |
[BP] GO:0040008 |
regulation of growth
|
ADRB1, BCL2, CSNK2A1, DRD2, DRD3, EGFR, ERBB2, ESR2, F2, PIM1 |
2.34949 |
[BP] GO:0006720 |
isoprenoid metabolic process
|
CYP1A1, CYP1A2, CYP1B1, CYP3A4, EGFR |
2.33991 |
[BP] GO:0050795 |
None
|
ADORA1, CNR1, DRD2, DRD3 |
2.33897 |
[BP] GO:0043393 |
regulation of protein binding
|
AURKB, BCL2, MET, MMP9, PPARA, SRC |
2.33126 |
[BP] GO:0006694 |
steroid biosynthetic process
|
AKR1B1, CYP19A1, CYP3A4, HSD17B1, HSD17B2 |
2.33126 |
[BP] GO:0006145 |
None
|
AOX1, XDH |
2.33126 |
[BP] GO:0038171 |
None
|
CNR1, CNR2 |
2.33126 |
[BP] GO:0018894 |
dibenzo-p-dioxin metabolic process
|
CYP1A1, CYP1A2 |
2.33126 |
[BP] GO:0009892 |
negative regulation of metabolic process
|
ADORA1, APEX1, AURKB, BCL2, CNR1, CNR2, CSNK2A1, DRD2, DRD3, EGFR, ESR1, ESR2, ESRRA, F2, FABP4, HCAR2, IGF1R, KDR, MET, MMP9, PPARA, SRC, XDH |
2.32339 |
[BP] GO:1903409 |
reactive oxygen species biosynthetic process
|
CYP1A1, CYP1A2, CYP1B1 |
2.31258 |
[BP] GO:0040014 |
regulation of multicellular organism growth
|
ADRB1, BCL2, DRD2, DRD3 |
2.27765 |
[BP] GO:0015908 |
None
|
DRD2, DRD3, FABP3, PPARA |
2.27765 |
[BP] GO:0072507 |
divalent inorganic cation homeostasis
|
BCL2, CACNA1C, DRD1, DRD2, DRD3, EGFR, ESR1, F2 |
2.27416 |
[BP] GO:0007167 |
enzyme linked receptor protein signaling pathway
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, MMP2, MMP9, SRC |
2.25923 |
[BP] GO:0040013 |
None
|
ADORA1, ADORA3, APEX1, BCL2, CYP19A1, CYP1B1, DRD2 |
2.25918 |
[BP] GO:0050708 |
None
|
ACHE, CACNA1C, CNR1, DRD2, DRD3, EGFR, HCAR2, SRC |
2.2352 |
[BP] GO:1903530 |
regulation of secretion by cell
|
ACHE, ADORA1, CACNA1C, CNR1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, SRC |
2.22317 |
[BP] GO:0070201 |
None
|
ACHE, BCL2, CACNA1C, CNR1, DRD2, DRD3, EGFR, ERBB2, F2, HCAR2, SRC |
2.22317 |
[BP] GO:0071495 |
cellular response to endogenous stimulus
|
AKR1B1, APEX1, DRD1, EGFR, ERBB2, ESR1, FLT3, IGF1R, MMP2, SRC |
2.22091 |
[BP] GO:0006706 |
steroid catabolic process
|
CYP19A1, CYP1A2, CYP3A4 |
2.22091 |
[BP] GO:0048545 |
response to steroid hormone
|
ALPL, BCL2, CA2, EGFR, FLT3, SRC |
2.20172 |
[BP] GO:0031099 |
regeneration
|
AXL, BCL2, CSNK2A1, EGFR, FLT3 |
2.20076 |
[BP] GO:0010557 |
positive regulation of macromolecule biosynthetic process
|
AURKB, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, IGF1R, KDR, MET, PPARA, SRC, TOP2A |
2.1975 |
[BP] GO:0009991 |
response to extracellular stimulus
|
ALPL, AXL, BCL2, CNR1, CYP1A1, EGFR, SRC, TYR |
2.19229 |
[BP] GO:0045745 |
None
|
DRD2, DRD3, F2 |
2.17877 |
[BP] GO:0050793 |
regulation of developmental process
|
ADRB1, AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESRRA, ESRRB, F2, F3, KDR, PIM1, PPARA, SRC, XDH |
2.17812 |
[BP] GO:0007189 |
None
|
ADRB1, DRD1, DRD2, DRD3 |
2.17812 |
[BP] GO:0001101 |
response to acid chemical
|
AKR1B1, EGFR, FABP3, HSD17B2, KDR, MMP2, SRC |
2.17763 |
[BP] GO:0042327 |
positive regulation of phosphorylation
|
ADORA1, BCL2, DRD2, EGFR, ERBB2, ESRRB, F2, FLT3, KDR, MMP9, SRC, XDH |
2.17763 |
[BP] GO:0016310 |
phosphorylation
|
AURKB, AXL, BCL2, CSNK2A1, DRD1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.1653 |
[BP] GO:0034762 |
None
|
BCL2, CA2, CACNA1C, DRD1, DRD2, DRD3, F2, MMP9 |
2.15469 |
[BP] GO:0021853 |
None
|
DRD1, DRD2 |
2.15469 |
[BP] GO:0010641 |
None
|
F3, SRC |
2.15469 |
[BP] GO:1904936 |
None
|
DRD1, DRD2 |
2.15469 |
[BP] GO:0042321 |
None
|
ADORA1, DRD2 |
2.15469 |
[BP] GO:0090325 |
None
|
DRD2, DRD3 |
2.15469 |
[BP] GO:0046320 |
None
|
CNR1, FABP3, PPARA |
2.15469 |
[BP] GO:0042417 |
None
|
DRD1, DRD2, DRD3 |
2.15469 |
[BP] GO:0008209 |
androgen metabolic process
|
CYP19A1, CYP3A4, ESR1 |
2.15469 |
[BP] GO:0014059 |
None
|
CNR1, DRD2, DRD3 |
2.15469 |
[BP] GO:0030003 |
cellular cation homeostasis
|
BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, F2 |
2.15469 |
[BP] GO:0009966 |
regulation of signal transduction
|
ADORA1, ADRB1, AKR1B1, AURKB, AXL, BCL2, CSNK2A1, CYP1B1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, F2, F3, FLT3, IGF1R, KDR, MET, MMP9, SRC, XDH |
2.13402 |
[BP] GO:0051130 |
positive regulation of cellular component organization
|
AURKB, AXL, BCL2, CNR1, DRD2, DRD3, ESR1, IGF1R, KDR, MET, MMP1, MMP9, SRC |
2.1145 |
[BP] GO:0031100 |
animal organ regeneration
|
AXL, CSNK2A1, EGFR, FLT3 |
2.11366 |
[BP] GO:0048661 |
positive regulation of smooth muscle cell proliferation
|
AKR1B1, EGFR, MMP2, MMP9 |
2.11366 |
[BP] GO:0019752 |
carboxylic acid metabolic process
|
ALOX5, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, FABP3, GLO1, PIM1, PPARA, TYR |
2.10599 |
[BP] GO:0046427 |
positive regulation of JAK-STAT cascade
|
AKR1B1, CYP1B1, F2, FLT3 |
2.09484 |
[BP] GO:0035556 |
intracellular signal transduction
|
ADRB1, AKR1B1, AXL, BCL2, CACNA1C, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, IGF1R, KDR, MET, SRC |
2.08783 |
[BP] GO:1900542 |
None
|
ADRB1, DRD1, DRD2, DRD3, ESRRB, PPARA |
2.08783 |
[BP] GO:0006873 |
cellular ion homeostasis
|
BCL2, CA2, CA7, CACNA1C, DRD1, DRD2, DRD3, ESR1, F2 |
2.08783 |
[BP] GO:0002682 |
regulation of immune system process
|
ADORA1, AXL, BCL2, CA2, CNR1, CNR2, CYP19A1, DRD2, ERBB2, ESR1, ESRRA, F2, HCAR2, MMP2, SRC |
2.08783 |
[BP] GO:2000026 |
regulation of multicellular organismal development
|
AXL, BCL2, CA2, CNR1, CYP1B1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESRRA, F2, F3, KDR, PIM1, SRC, XDH |
2.08351 |
[BP] GO:0035265 |
organ growth
|
BCL2, CYP19A1, ESR1 |
2.08089 |
[BP] GO:0042743 |
hydrogen peroxide metabolic process
|
CYP1A1, CYP1A2, EGFR |
2.08089 |
[BP] GO:0071248 |
cellular response to metal ion
|
CYP1A1, CYP1A2, EGFR, FABP4, MMP9 |
2.07451 |
[BP] GO:0080090 |
regulation of primary metabolic process
|
ADORA1, ADORA3, ADRB1, APEX1, AURKB, BCL2, CA9, CNR1, CSNK2A1, CYP1A1, CYP1B1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GLO1, HCAR2, IGF1R, KDR, MET, MMP9, PIM1, PPARA, SRC, TOP2A, XDH |
2.0661 |
[BP] GO:0045935 |
positive regulation of nucleobase-containing compound metabolic process
|
ADRB1, AURKB, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, IGF1R, MET, PPARA, SRC, TOP2A |
2.06482 |
[BP] GO:1904894 |
positive regulation of STAT cascade
|
AKR1B1, CYP1B1, F2, FLT3 |
2.06482 |
[BP] GO:0032880 |
regulation of protein localization
|
ACHE, BCL2, CACNA1C, CNR1, CSNK2A1, DRD2, DRD3, EGFR, ERBB2, F2, HCAR2, SRC |
2.06194 |
[BP] GO:0001763 |
morphogenesis of a branching structure
|
BCL2, DRD2, ESR1, MET, SRC |
2.05313 |
[BP] GO:0042220 |
None
|
CNR1, DRD2, DRD3 |
2.04954 |
[BP] GO:0071276 |
cellular response to cadmium ion
|
CYP1A2, EGFR, MMP9 |
2.04954 |
[BP] GO:0045744 |
None
|
DRD2, DRD3, MET |
2.04954 |
[BP] GO:0010039 |
response to iron ion
|
BCL2, CYP1A1, DRD2 |
2.04954 |
[BP] GO:0006140 |
None
|
ADRB1, DRD1, DRD2, DRD3, ESRRB, PPARA |
2.03549 |
[BP] GO:0051046 |
None
|
ACHE, ADORA1, CACNA1C, CNR1, CYP19A1, DRD2, DRD3, EGFR, HCAR2, SRC |
2.03051 |
[BP] GO:0051128 |
regulation of cellular component organization
|
AURKB, AXL, BCL2, CNR1, CSNK2A1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, F2, IGF1R, KDR, MET, MMP1, MMP9, SRC, TOP2A |
2.03051 |
[BP] GO:0021843 |
None
|
DRD1, DRD2 |
2.03051 |
[BP] GO:0051902 |
negative regulation of mitochondrial depolarization
|
BCL2, SRC |
2.03051 |
[BP] GO:0046113 |
None
|
AOX1, XDH |
2.03051 |
[BP] GO:0021830 |
None
|
DRD1, DRD2 |
2.03051 |
[BP] GO:0032229 |
None
|
ADORA1, CNR2 |
2.03051 |
[BP] GO:0002933 |
lipid hydroxylation
|
CYP1A1, CYP3A4 |
2.03051 |
[BP] GO:0021826 |
None
|
DRD1, DRD2 |
2.03051 |
[BP] GO:0016098 |
monoterpenoid metabolic process
|
CYP1A2, CYP3A4 |
2.03051 |
[BP] GO:0001932 |
regulation of protein phosphorylation
|
ADORA1, BCL2, DRD1, DRD2, EGFR, ERBB2, F2, FABP4, FLT3, IGF1R, KDR, MMP9, SRC, XDH |
2.03051 |
[BP] GO:0033273 |
response to vitamin
|
ALPL, CYP1A1, EGFR, TYR |
2.03051 |
[BP] GO:0022029 |
None
|
DRD1, DRD2, EGFR |
2.03051 |
[BP] GO:0043278 |
None
|
CNR1, DRD2, DRD3 |
2.03051 |
[BP] GO:0014072 |
None
|
CNR1, DRD2, DRD3 |
2.03051 |
[BP] GO:0098801 |
None
|
ADORA1, DRD2, DRD3 |
2.03051 |
[BP] GO:0042596 |
None
|
ADRB1, BCL2, DRD1 |
2.03051 |
[BP] GO:0044093 |
positive regulation of molecular function
|
ADORA1, ADRB1, AURKB, BCL2, DRD2, EGFR, ERBB2, ESR1, ESR2, F2, F3, FLT3, MET, MMP9, SRC, XDH |
2.02967 |
[BP] GO:0003006 |
developmental process involved in reproduction
|
ALPL, AXL, BCL2, CYP19A1, EGFR, ESR1, ESRRB, HSD17B2, SRC |
2.02363 |
[BP] GO:0031960 |
response to corticosteroid
|
ALPL, BCL2, EGFR, FLT3, SRC |
2.01834 |
[BP] GO:0003018 |
None
|
ADORA1, ADRB1, DRD1, EGFR, SRC |
2.01834 |
[CC] GO:0005886 |
plasma membrane
|
ACHE, ADORA1, ADORA3, ADRB1, ALPL, AXL, CA12, CA14, CA2, CA4, CA9, CACNA1C, CNR1, CNR2, CSNK2A1, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, F2, F3, FLT3, GLO1, HCAR2, IGF1R, KDR, MET, MMP2, PIM1, SRC |
3.30561 |
[CC] GO:0016020 |
membrane
|
ACHE, ADORA1, ADORA3, ADRB1, ALOX5, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CNR1, CNR2, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, F2, F3, FLT3, FUT7, GLO1, HCAR2, HSD17B2, IGF1R, KDR, MET, MMP2, PIM1, SRC, TYR |
2.93931 |
[CC] GO:0044444 |
cytoplasmic part
|
ACHE, ADORA1, ADRB1, AKR1B1, ALOX5, AOX1, APEX1, AURKB, BCL2, CA1, CA2, CA3, CA4, CA5A, CA5B, CA7, CACNA1C, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, F2, FABP3, FABP4, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, KDR, MMP2, MMP9, PIM1, SRC, TOP2A, TYR, XDH |
2.7931 |
[CC] GO:0044425 |
membrane part
|
ACHE, ADORA1, ADORA3, ADRB1, ALPL, AXL, BCL2, CA12, CA14, CA2, CA4, CA9, CACNA1C, CNR1, CNR2, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, F2, F3, FLT3, FUT7, HCAR2, HSD17B2, IGF1R, KDR, MET, SRC, TYR |
2.54428 |
[CC] GO:0044459 |
plasma membrane part
|
ADORA1, ADORA3, ADRB1, AXL, CA2, CA4, CA9, CACNA1C, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ERBB2, F2, F3, FLT3, IGF1R, KDR, MET, SRC |
2.53604 |
[CC] GO:0016323 |
basolateral plasma membrane
|
ADORA1, CA2, CA4, CA9, EGFR, ERBB2 |
2.50492 |
[CC] GO:0031226 |
intrinsic component of plasma membrane
|
ADORA1, ADORA3, ADRB1, AXL, CA4, CNR1, CNR2, DRD1, DRD2, DRD3, F3, FLT3, IGF1R, KDR, MET |
2.23456 |
[MF] GO:0004089 |
carbonate dehydratase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
20.1222 |
[MF] GO:0046914 |
transition metal ion binding
|
ALOX5, AOX1, CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP2, MMP9, PIM1, PPARA, TYR, XDH |
17.344 |
[MF] GO:0043167 |
ion binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, FLT3, GLO1, HSD17B1, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, PPARA, SRC, TOP2A, TYR, XDH |
14.007 |
[MF] GO:0016835 |
carbon-oxygen lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
13.1576 |
[MF] GO:0016836 |
hydro-lyase activity
|
CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9 |
13.0691 |
[MF] GO:0016829 |
lyase activity
|
APEX1, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, GLO1 |
10.0942 |
[MF] GO:0043169 |
cation binding
|
ACHE, ALOX5, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, DRD1, DRD2, DRD3, ESR1, ESR2, ESRRA, ESRRB, F2, GLO1, MMP1, MMP2, MMP9, PIM1, PPARA, TOP2A, TYR, XDH |
9.5577 |
[MF] GO:0003824 |
catalytic activity
|
ACHE, ADORA1, AKR1B1, ALOX5, ALPL, AOX1, APEX1, AURKB, AXL, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, EGFR, ERBB2, F2, F3, FLT3, FUT7, GLO1, HSD17B1, HSD17B2, IGF1R, KDR, MET, MMP1, MMP2, MMP9, PIM1, SRC, TOP2A, TYR, XDH |
8.76735 |
[MF] GO:0016712 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4 |
8.52557 |
[MF] GO:0008270 |
zinc ion binding
|
CA1, CA12, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, ESR1, ESR2, ESRRA, ESRRB, GLO1, MMP1, MMP2, MMP9, PPARA |
7.95751 |
[MF] GO:0038023 |
signaling receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HCAR2, IGF1R, KDR, MET, PPARA |
7.44369 |
[MF] GO:0046872 |
metal ion binding
|
ALOX5, ALPL, AOX1, APEX1, AURKB, CA1, CA12, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA9, CACNA1C, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F2, GLO1, MMP1, MMP2, MMP9, PIM1, PPARA, TOP2A, TYR, XDH |
7.19049 |
[MF] GO:0070330 |
aromatase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
7.09529 |
[MF] GO:0005506 |
iron ion binding
|
ALOX5, AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, XDH |
7.01137 |
[MF] GO:0004872 |
receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HCAR2, IGF1R, KDR, MET, PPARA |
6.61139 |
[MF] GO:0008144 |
drug binding
|
ACHE, AURKB, AXL, CNR1, CSNK2A1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4, DRD1, DRD2, DRD3, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, PPARA, SRC, TOP2A |
6.49961 |
[MF] GO:0060089 |
molecular transducer activity
|
ADORA1, ADORA3, ADRB1, AXL, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HCAR2, IGF1R, KDR, MET, PPARA |
6.36158 |
[MF] GO:0004497 |
monooxygenase activity
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, TYR |
6.32684 |
[MF] GO:0004714 |
transmembrane receptor protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
6.19649 |
[MF] GO:0004871 |
signal transducer activity
|
ADORA1, ADORA3, ADRB1, AXL, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ERBB2, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FLT3, HCAR2, IGF1R, KDR, MET, PPARA |
5.88193 |
[MF] GO:0019199 |
transmembrane receptor protein kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET |
5.56225 |
[MF] GO:0019825 |
oxygen binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP3A4 |
5.56225 |
[MF] GO:0020037 |
heme binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, SRC |
5.46706 |
[MF] GO:0016491 |
oxidoreductase activity
|
AKR1B1, ALOX5, AOX1, APEX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HSD17B1, HSD17B2, TYR, XDH |
5.37364 |
[MF] GO:0046906 |
tetrapyrrole binding
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, SRC |
5.2457 |
[MF] GO:0016705 |
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen
|
CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, TYR |
4.89496 |
[MF] GO:0008395 |
steroid hydroxylase activity
|
CYP19A1, CYP1A1, CYP2A13, CYP2A6, CYP3A4 |
4.64248 |
[MF] GO:0004713 |
protein tyrosine kinase activity
|
AXL, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, SRC |
4.43229 |
[MF] GO:0005496 |
steroid binding
|
CYP3A4, ESR1, ESR2, ESRRA, ESRRB, HSD17B1 |
4.06313 |
[MF] GO:1901338 |
None
|
ADRB1, DRD1, DRD2, DRD3 |
3.97625 |
[MF] GO:0099600 |
transmembrane receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, HCAR2, IGF1R, KDR, MET |
3.97285 |
[MF] GO:0004888 |
transmembrane signaling receptor activity
|
ADORA1, ADORA3, ADRB1, AXL, CNR1, CNR2, DRD1, DRD2, DRD3, EGFR, ERBB2, F3, FLT3, HCAR2, IGF1R, KDR, MET |
3.97285 |
[MF] GO:0048037 |
cofactor binding
|
AOX1, CYP19A1, CYP1A1, CYP1A2, CYP1B1, CYP2A13, CYP2A6, CYP3A4, HSD17B1, SRC, XDH |
3.97098 |
[MF] GO:0098531 |
transcription factor activity, direct ligand regulated sequence-specific DNA binding
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.93262 |
[MF] GO:0004879 |
nuclear receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.93262 |
[MF] GO:0003707 |
steroid hormone receptor activity
|
ESR1, ESR2, ESRRA, ESRRB, PPARA |
3.57375 |
[MF] GO:0008289 |
lipid binding
|
AXL, CYP3A4, ESR1, ESR2, ESRRA, ESRRB, F2, F3, FABP3, FABP4, HSD17B1, PPARA |
3.46401 |
[MF] GO:0016725 |
oxidoreductase activity, acting on CH or CH2 groups
|
CYP1A2, CYP3A4, XDH |
3.37362 |
[MF] GO:0004716 |
signal transducer, downstream of receptor, with protein tyrosine kinase activity
|
EGFR, ERBB2, KDR |
3.37362 |
[MF] GO:0004952 |
None
|
DRD1, DRD2, DRD3 |
3.0311 |
[MF] GO:0035240 |
None
|
DRD1, DRD2, DRD3 |
2.94095 |
[MF] GO:0004672 |
protein kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.9329 |
[MF] GO:0038052 |
RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding
|
ESR1, ESR2 |
2.91579 |
[MF] GO:0008389 |
None
|
CYP2A13, CYP2A6 |
2.91579 |
[MF] GO:0042802 |
identical protein binding
|
ACHE, AOX1, BCL2, CSNK2A1, DRD2, EGFR, ERBB2, ESR1, ESR2, FLT3, IGF1R, KDR, MET, MMP9, TOP2A, TYR, XDH |
2.72518 |
[MF] GO:0044877 |
macromolecular complex binding
|
ACHE, ADORA1, APEX1, CSNK2A1, EGFR, ESRRB, FLT3, IGF1R, KDR, MMP9, PIM1, PPARA, SRC |
2.69329 |
[MF] GO:0009055 |
electron transfer activity
|
AKR1B1, AOX1, CYP19A1, CYP1A2, XDH |
2.56182 |
[MF] GO:0070576 |
vitamin D 24-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.54706 |
[MF] GO:0004949 |
None
|
CNR1, CNR2 |
2.54706 |
[MF] GO:0046982 |
protein heterodimerization activity
|
ADORA1, ADRB1, AXL, BCL2, DRD2, EGFR, ERBB2, TOP2A, TYR |
2.48524 |
[MF] GO:0016773 |
phosphotransferase activity, alcohol group as acceptor
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.372 |
[MF] GO:0032403 |
protein complex binding
|
ACHE, ADORA1, APEX1, EGFR, ESRRB, FLT3, IGF1R, KDR, MMP9, PPARA, SRC |
2.34246 |
[MF] GO:0034056 |
estrogen response element binding
|
ESR1, ESR2 |
2.33126 |
[MF] GO:0034875 |
caffeine oxidase activity
|
CYP1A2, CYP3A4 |
2.33126 |
[MF] GO:0033695 |
oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor
|
CYP1A2, CYP3A4 |
2.33126 |
[MF] GO:0016614 |
oxidoreductase activity, acting on CH-OH group of donors
|
AKR1B1, AOX1, HSD17B1, HSD17B2, XDH |
2.20076 |
[MF] GO:0070405 |
ammonium ion binding
|
ACHE, DRD1, DRD2, DRD3 |
2.15994 |
[MF] GO:0101020 |
estrogen 16-alpha-hydroxylase activity
|
CYP1A1, CYP3A4 |
2.15469 |
[MF] GO:0030284 |
estrogen receptor activity
|
ESR1, ESR2 |
2.15469 |
[MF] GO:0016301 |
kinase activity
|
AURKB, AXL, CSNK2A1, EGFR, ERBB2, FLT3, IGF1R, KDR, MET, PIM1, SRC |
2.11366 |
[MF] GO:0004064 |
arylesterase activity
|
CA1, CA2 |
2.03051 |
[MF] GO:0043546 |
None
|
AOX1, XDH |
2.03051 |